| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Vascular and Interventional Radiology |
1 From the Department of Diagnostic and Interventional Radiology, J. W. Goethe University of Frankfurt, Theodor-Stern-Kai 7, 63590 Frankfurt, Germany (T.J.V., M.T., H.S., M.M., J.S.); and the Departments of Radiology (A.S., R.F.) and Surgery (P.N.), Humbolt-University of Berlin, Germany. Received January 20, 1999; revision requested March 22; revision received May 6; accepted July 30. Address reprint requests to T.J.V. (e-mail: T.Vogl@em.uni .Frankfurt.de).
PURPOSE: To evaluate the prognostic value of volumetric computed tomography (CT) for therapy control in patients treated with repeated transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Eighty-five patients with histologically proved HCC underwent 182 TACE procedures with 50 mg/m2 doxorubicin hydrochloride, 50 mg/m2 cisplatin, 10 mL/m2 iodized oil, and amilomer microspheres. The volumes of liver and tumor were measured with a region-of-interest CT technique. Iodized oil retention was estimated with CT performed 24–48 hours after treatment.
RESULTS: Tumor volume expressed as a percentage of liver volume was less than 5% in 26, less than 15% in 33, and 15% or greater in 26 patients. The overall 1-year survival rate was 57.6% (mean, 534 days; median, 428 days). There was a statistically significant prolongation of survival when the tumor volume was less than 200 mL (P < .02) and less than 5% of the liver volume (P < .01). Complete (
75%) and good (50%–74%) iodized oil retention raised the median survival significantly (P < .001 and P < .07, respectively). Significantly reduced survival correlated with diffuse tumor growth pattern (P < .05) and presence of more than nine lesions (P < .03).
CONCLUSION: TACE resulted in significant prolongation of survival in patients with tumor volumes of less than 200 mL, tumor-to-liver volume ratios of less than 5%, and iodized oil retention greater than or equal to 75%.
Index terms: Arteries, therapeutic embolization, 952.1264, 952.1266 • Computed tomography (CT), volume rendering, 761.12111, 761.12112, 761.12115 • Liver neoplasms, 761.323 • Liver neoplasms, chemotherapeutic embolization, 761.1266, 952.1266 • Liver neoplasms, CT, 761.12111, 761.12112, 761.12115
This article has been cited by other articles:
|
|
 |
|
  T. J. Vogl, T. Gruber, J. O. Balzer, K. Eichler, R. Hammerstingl, and S. Zangos Repeated Transarterial Chemoembolization in the Treatment of Liver Metastases of Colorectal Cancer: Prospective Study Radiology, January 1, 2009; 250(1): 281 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-Y. Chen, C.-W. Li, Y.-T. Kuo, T.-S. Jaw, D.-K. Wu, J.-C. Jao, J.-S. Hsu, and G.-C. Liu Early Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization: Choline Levels and MR Diffusion Constants--Initial Experience Radiology, May 1, 2006; 239(2): 448 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Kan, S. Kobayashi, S. Phongkitkarun, and C. Charnsangavej Functional CT Quantification of Tumor Perfusion after Transhepatic Arterial Embolization in a Rat Model Radiology, October 1, 2005; 237(1): 144 - 150. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Farraher, H. Jara, K. J. Chang, A. Hou, and J. A. Soto Liver and Spleen Volumetry with Quantitative MR Imaging and Dual-Space Clustering Segmentation Radiology, October 1, 2005; 237(1): 322 - 328. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Ueno, D. Aoki, F. Kubo, K. Hiwatashi, K. Matsushita, T. Oyama, I. Maruyama, and T. Aikou Roxithromycin Inhibits Constitutive Activation of Nuclear Factor {kappa}B by Diminishing Oxidative Stress in a Rat Model of Hepatocellular Carcinoma Clin. Cancer Res., August 1, 2005; 11(15): 5645 - 5650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Thomas and A. X. Zhu Hepatocellular Carcinoma: The Need for Progress J. Clin. Oncol., May 1, 2005; 23(13): 2892 - 2899. [Full Text] [PDF]
|
|
|
|
|
|
T. J. Vogl, A. Wetter, S. Lindemayr, and S. Zangos Treatment of Unresectable Lung Metastases with Transpulmonary Chemoembolization: Preliminary Experience Radiology, March 1, 2005; 234(3): 917 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schiemann, R. Killmann, M. Kleen, N. Abolmaali, J. Finney, and T. J. Vogl Vascular Guide Wire Navigation with a Magnetic Guidance System: Experimental Results in a Phantom Radiology, August 1, 2004; 232(2): 475 - 481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R.-C. Chen, L.-Y. Liao, C.-S. Wang, W.-T. Chen, C.-K. Wang, Y.-H. Li, H.-Y. Tu, and P.-H. Chen Carbon Dioxide-Enhanced Sonographically Guided Percutaneous Ethanol Injection: Treatment of Patients with Viable and Recurrent Hepatocellular Carcinoma Am. J. Roentgenol., December 1, 2003; 181(6): 1647 - 1652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. J. Vogl, M. G. Mack, J. O. Balzer, K. Engelmann, R. Straub, K. Eichler, D. Woitaschek, and S. Zangos Liver Metastases: Neoadjuvant Downsizing with Transarterial Chemoembolization before Laser-Induced Thermotherapy Radiology, November 1, 2003; 229(2): 457 - 464. [Abstract] [Full Text] [PDF]
|
|
